| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |